# NURS 6521N TEST BANK
Advanced Pharmacology
Midterm Exam
,## Multiple Choice Questions with Explanations
### Walden University - Latest 2026/2027 Update
---
## SECTION 1: PHARMACOKINETICS AND PHARMACODYNAMICS (Questions 1-30)
**Question 1**
A 65-year-old patient with renal impairment is prescribed a medication that is primarily excreted renally. What
pharmacokinetic parameter should the nurse anticipate will be most affected?
A) Bioavailability
B) Volume of distribution
C) Half-life
D) Protein binding
**Answer: C) Half-life**
*Rationale:* In renal impairment, drug excretion is reduced, leading to an increased half-life. This means the drug will
remain in the body longer, requiring dose adjustment. Bioavailability is primarily affected by first-pass metabolism;
volume of distribution is affected by body composition changes; protein binding is affected by albumin levels, not
directly by renal function.
---
**Question 2**
A medication has a half-life of 4 hours. Approximately how many hours will it take for the drug to reach steady state?
A) 8 hours
B) 12 hours
C) 16 hours
D) 20 hours
,**Answer: D) 20 hours**
*Rationale:* Steady state is achieved after approximately 4-5 half-lives. With a 4-hour half-life, 5 half-lives = 20
hours (4 × 5 = 20 hours). At steady state, the rate of drug administration equals the rate of elimination.
---
**Question 3**
Which route of administration results in 100% bioavailability?
A) Oral
B) Subcutaneous
C) Intravenous
D) Intramuscular
**Answer: C) Intravenous**
*Rationale:* IV administration delivers the drug directly into the systemic circulation, bypassing first-pass metabolism and
absorption barriers, resulting in 100% bioavailability. Oral drugs undergo first-pass metabolism; subcutaneous and
intramuscular routes have absorption barriers.
---
**Question 4**
The nurse understands that the blood-brain barrier limits drug distribution to the brain due to:
A) High lipid solubility of drugs
B) Tight junctions between endothelial cells
C) Active transport mechanisms
D) Low protein binding in plasma
**Answer: B) Tight junctions between endothelial cells**
, *Rationale:* The blood-brain barrier consists of endothelial cells with tight junctions that restrict passage of water-
soluble and large molecules. Only lipid-soluble drugs or those with specific transport mechanisms can cross. Tight junctions
are the primary structural feature limiting distribution.
---
**Question 5**
A patient with liver cirrhosis is prescribed a medication with high first-pass metabolism. The nurse anticipates:
A) Decreased drug effect
B) Increased drug bioavailability
C) No change in drug levels
D) Faster drug clearance
**Answer: B) Increased drug bioavailability**
*Rationale:* Liver cirrhosis reduces hepatic blood flow and metabolic capacity, decreasing first-pass metabolism. This
results in a larger proportion of the drug reaching systemic circulation, increasing bioavailability and potentially leading
to toxicity if doses aren't adjusted.
---
**Question 6**
Which CYP450 enzyme is responsible for metabolizing the largest percentage of clinically used drugs?
A) CYP1A2
B) CYP2D6
C) CYP3A4
D) CYP2C9
**Answer: C) CYP3A4**
Advanced Pharmacology
Midterm Exam
,## Multiple Choice Questions with Explanations
### Walden University - Latest 2026/2027 Update
---
## SECTION 1: PHARMACOKINETICS AND PHARMACODYNAMICS (Questions 1-30)
**Question 1**
A 65-year-old patient with renal impairment is prescribed a medication that is primarily excreted renally. What
pharmacokinetic parameter should the nurse anticipate will be most affected?
A) Bioavailability
B) Volume of distribution
C) Half-life
D) Protein binding
**Answer: C) Half-life**
*Rationale:* In renal impairment, drug excretion is reduced, leading to an increased half-life. This means the drug will
remain in the body longer, requiring dose adjustment. Bioavailability is primarily affected by first-pass metabolism;
volume of distribution is affected by body composition changes; protein binding is affected by albumin levels, not
directly by renal function.
---
**Question 2**
A medication has a half-life of 4 hours. Approximately how many hours will it take for the drug to reach steady state?
A) 8 hours
B) 12 hours
C) 16 hours
D) 20 hours
,**Answer: D) 20 hours**
*Rationale:* Steady state is achieved after approximately 4-5 half-lives. With a 4-hour half-life, 5 half-lives = 20
hours (4 × 5 = 20 hours). At steady state, the rate of drug administration equals the rate of elimination.
---
**Question 3**
Which route of administration results in 100% bioavailability?
A) Oral
B) Subcutaneous
C) Intravenous
D) Intramuscular
**Answer: C) Intravenous**
*Rationale:* IV administration delivers the drug directly into the systemic circulation, bypassing first-pass metabolism and
absorption barriers, resulting in 100% bioavailability. Oral drugs undergo first-pass metabolism; subcutaneous and
intramuscular routes have absorption barriers.
---
**Question 4**
The nurse understands that the blood-brain barrier limits drug distribution to the brain due to:
A) High lipid solubility of drugs
B) Tight junctions between endothelial cells
C) Active transport mechanisms
D) Low protein binding in plasma
**Answer: B) Tight junctions between endothelial cells**
, *Rationale:* The blood-brain barrier consists of endothelial cells with tight junctions that restrict passage of water-
soluble and large molecules. Only lipid-soluble drugs or those with specific transport mechanisms can cross. Tight junctions
are the primary structural feature limiting distribution.
---
**Question 5**
A patient with liver cirrhosis is prescribed a medication with high first-pass metabolism. The nurse anticipates:
A) Decreased drug effect
B) Increased drug bioavailability
C) No change in drug levels
D) Faster drug clearance
**Answer: B) Increased drug bioavailability**
*Rationale:* Liver cirrhosis reduces hepatic blood flow and metabolic capacity, decreasing first-pass metabolism. This
results in a larger proportion of the drug reaching systemic circulation, increasing bioavailability and potentially leading
to toxicity if doses aren't adjusted.
---
**Question 6**
Which CYP450 enzyme is responsible for metabolizing the largest percentage of clinically used drugs?
A) CYP1A2
B) CYP2D6
C) CYP3A4
D) CYP2C9
**Answer: C) CYP3A4**
